Drugs may be given during the peri-transplant (before and after infusion) period to prevent transplant-related complications, such as liver injuries or to facilitate engraftment.
Questions 157 – 161: Drugs
For each agent listed, indicate whether the drug was administered during the peri-transplant period to prevent transplant-related complications or facilitate engraftment, and any additional question(s) for each drug administered.
- ALG (Anti-Lymphocyte Globulin), ALS (Anti-Lymphocyte Serum), ATG (Anti-Thymocyte Globulin, ATS (Anti-Thymocyte Serum): Serum or gamma globulin preparations containing polyclonal immunoglobulins directed against lymphocytes. These drugs are usually prepared from animals immunized against human lymphocytes. Report the total dose prescribed pre- and post-infusion and the animal source. If Other is selected, specify the source.
- Alemtuzumab (Campath): Antibody preparations that are infused in the recipient. Report the total dose prescribed pre- and post-infusion to the nearest tenth and specify the units of measurement.
- Defibrotide: Antithrombotic agent used to prevent veno-occlusive disease.
- Ursodiol: A naturally occurring bile acid used to dissolve small gall stones and to increase bile flow in patients with primary biliary cirrhosis.
If the recipient did not receive any of the drugs listed above, select None.
Section Updates:
| Question Number | Date of Change | Add/Remove/Modify | Description | Reasoning (If applicable) |
|---|---|---|---|---|
| . | . | . | . | . |
Last modified:
Oct 27, 2025
Need more help with this?
Don’t hesitate to contact us here.